Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Whyte

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Cancer Causes & Control : CCC|April 1, 2014
Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling studySophie Whyte, Susan Harnan
Pharmacoeconomics|October 13, 2012
Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisalSophie Whyte, Abdullah Pandor, Matt Stevenson
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 4, 2010
Bayesian calibration of a natural history model with application to a population model for colorectal cancerSophie Whyte, Cathal Walsh, Jim Chilcott
Preventive Medicine|July 8, 2022
Modelling cost-effective strategies for minimising socioeconomic inequalities in colorectal cancer screening outcomes in EnglandChloe Thomas, Olena Mandrik, Sophie Whyte
Pharmacoeconomics|January 7, 2022
Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and SolutionsOlena Mandrik, Chloe Thomas, Sophie Whyte, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic PerspectiveSophie Whyte, Chloe Thomas, Jim Chilcott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 30, 2019
External Validation of a Colorectal Cancer Model Against Screening Trial Long-Term Follow-Up DataChloe Thomas, Sophie Whyte, Benjamin Kearns, et al.
BMC Medicine|December 7, 2016
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluationBen Kearns, Jim Chilcott, Sophie Whyte, et al.
Health Economics|May 7, 2014
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening ProgrammeMiqdad Asaria, Susan Griffin, Richard Cookson, et al.
Pharmacoeconomics|October 30, 2017
A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity AnalysisShijie Ren, Jonathan Minton, Sophie Whyte, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Cancer Causes & Control : CCC|April 1, 2014
Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling studySophie Whyte, Susan Harnan
Pharmacoeconomics|October 13, 2012
Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisalSophie Whyte, Abdullah Pandor, Matt Stevenson
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 4, 2010
Bayesian calibration of a natural history model with application to a population model for colorectal cancerSophie Whyte, Cathal Walsh, Jim Chilcott
Preventive Medicine|July 8, 2022
Modelling cost-effective strategies for minimising socioeconomic inequalities in colorectal cancer screening outcomes in EnglandChloe Thomas, Olena Mandrik, Sophie Whyte
Pharmacoeconomics|January 7, 2022
Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and SolutionsOlena Mandrik, Chloe Thomas, Sophie Whyte, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic PerspectiveSophie Whyte, Chloe Thomas, Jim Chilcott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 30, 2019
External Validation of a Colorectal Cancer Model Against Screening Trial Long-Term Follow-Up DataChloe Thomas, Sophie Whyte, Benjamin Kearns, et al.
BMC Medicine|December 7, 2016
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluationBen Kearns, Jim Chilcott, Sophie Whyte, et al.
Health Economics|May 7, 2014
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening ProgrammeMiqdad Asaria, Susan Griffin, Richard Cookson, et al.
Pharmacoeconomics|October 30, 2017
A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity AnalysisShijie Ren, Jonathan Minton, Sophie Whyte, et al.
Pageof 4